Analyst Ratings ChangesĪ number of analysts recently issued reports on the company. Hedge funds and other institutional investors own 38.19% of the company's stock. now owns 22,749 shares of the company's stock valued at $1,253,000 after purchasing an additional 20,227 shares during the period. boosted its holdings in shares of AppLovin by 802.0% in the first quarter. now owns 9,425 shares of the company's stock valued at $519,000 after purchasing an additional 2,858 shares during the period. Cambridge Investment Research Advisors Inc. boosted its holdings in shares of AppLovin by 43.5% in the first quarter. Bank of New York Mellon Corp now owns 39,124 shares of the company's stock valued at $2,155,000 after purchasing an additional 6,942 shares during the period. Bank of New York Mellon Corp boosted its holdings in shares of AppLovin by 21.6% in the first quarter. Raymond James & Associates now owns 57,743 shares of the company's stock valued at $3,180,000 after purchasing an additional 30,112 shares during the period. Raymond James & Associates boosted its holdings in shares of AppLovin by 109.0% in the first quarter. now owns 981 shares of the company's stock valued at $54,000 after purchasing an additional 488 shares during the period. boosted its holdings in shares of AppLovin by 99.0% in the first quarter. Other large investors have also modified their holdings of the company. Light Street Capital Management LLC owned 0.25% of AppLovin worth $18,528,000 at the end of the most recent quarter. AppLovin comprises approximately 4.7% of Light Street Capital Management LLC's investment portfolio, making the stock its 11th biggest position. The firm owned 950,664 shares of the company's stock after selling 37,816 shares during the period. ( NYSE:APP - Get Rating) by 3.8% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). Light Street Capital Management LLC lessened its holdings in shares of AppLovin Co. Target Offering A Rare Buying Opportunity After Earnings.Rivian Gives Investors a Taste of the Anxiety Its Consumers Feel.Has Workhorse Group Finally Hit Bottom?.Wall Street Sees 23% Upside In Revance, Maker Of Botox Competitor.It’s Do or Die for Opendoor: Can It Survive a Real Estate Slump?.3 Mid-Caps Below $20 That Wall Street Loves.West Fraser's Earnings Scream Timber, Outlook Says Buy.It’s Time For A Fresh Look At The Kroger Co.Here’s Why Ross Could Soon Be Hitting All Time Highs.Hormel Hits 2-Year Low, And The Dip Gets Bought.AbbVie Stock Still a Solid Buy Despite Challenges.Home Depot Stock Earnings Slide, Long Term Value Still There.The Trader's Guide to Equities Research.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |